←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Antisense Oligonucleotides
Adrian Krainer
PhD
🏢Cold Spring Harbor Laboratory🌐USA
St. Giles Foundation Professor
100
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Adrian Krainer discovered the mechanism of splice-switching antisense oligonucleotides and developed nusinersen (Spinraza) for spinal muscular atrophy, the first approved splice-modulating ASO. His laboratory extends splice correction to cancer applications. He is a foundational figure in RNA splicing and ASO therapeutics.
Share:
🧪Research Fields 研究领域
RNA splicing
splice-switching ASO
SMA nusinersen
cancer splicing correction
SR proteins
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Adrian Krainer 的研究动态
Follow Adrian Krainer's research updates
留下邮箱，当我们发布与 Adrian Krainer（Cold Spring Harbor Laboratory）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment